Michael Eisen discusses a move in Congress to overturn a National Institutes of Health policy ensuring free access to results of taxpayer-funded biomedical research. "The policy has been quite unpopular with a powerful publishing cartels that are hellbent on denying US taxpayers access to and benefits from research they paid to produce," Eisen writes. More comment from Michelle Clement on the Scientific American blog network.
.png)
